MAPT and Alzheimer disease: In 9-month 3×Tg AD mice, 5 mM DEPTAC significantly reduced phospho-tau and total tau levels in the hippocampus when repeatedly delivered for a consecutive month (once every 3 days, 1 μL each), though the effectiveness was relatively limited when administrated for once (Supplementary Fig. S5).